Feeds:
Posts
Comments

Archive for the ‘Cancer aggression’ Category

AUGUST 4: URO TODAY: A new UK study may have implications on understanding pathways of prostate cancer progression and on identifying potential targets for screening – pending further investigation of associations between PSA testing, Gleason score, and cancer stage.

Read Full Post »

JULY 4: URO TODAY: US researchers claim to have developed a patient-specific, biology-driven tool to predict outcome at the time of prostate cancer diagnosis.

Read Full Post »

JUNE 19: NEW P[ROSTATE CANCER INFOLINK: One of the major issues in the management of prostate cancer is the identification of early physical (as opposed to biochemical) evidence of metastatic disease.

Read Full Post »

JUNE 13: NEW PROSTATE CANCER INFO-LINK: According to a report today on NJ.com, there are suggestions that defective “autophagy” — the process through which a cell “self-digests” because of the action of enzymes originating within the same cell — may be crucial to the amount and aggressiveness of at least some cancers.

Read Full Post »

JUNE 13: URO TODAY: WAVE3 is pivotal in controlling the invasiveness of prostate cancer cells, according to a new study at Cardiff University School of Medicine in the UK.

Read Full Post »

JUNE 12: HEALTH CARE BLOG: Researchers have found that although hormone therapy helps prevent growth of the prostate cancer, the treatment also changes its properties, thereby making the tumour more aggressive.

Read Full Post »

JUNE 10: BAYLOR COLLEGE: The extent of change to stroma – the supportive framework of the prostate gland – caused by prostate cancer may be an indication of disease aggression, say researchers at Baylor College of Medicine in a report that appears in the current issue of the journal Clinical Cancer Research.

Read Full Post »

Follow

Get every new post delivered to your Inbox.